Literature DB >> 26677753

Minireview: Mouse Models of Rho GTPase Function in Mammary Gland Development, Tumorigenesis, and Metastasis.

Yan Zuo1, Wonkyung Oh1, Arzu Ulu1, Jeffrey A Frost1.   

Abstract

Ras homolog (Rho) family small GTPases are critical regulators of actin cytoskeletal organization, cell motility, proliferation, and survival. Surprisingly, the large majority of the studies underlying our knowledge of Rho protein function have been carried out in cultured cells, and it is only recently that researchers have begun to assess Rho GTPase regulation and function in vivo. The purpose of this review is to evaluate our current knowledge of Rho GTPase function in mouse mammary gland development, tumorigenesis and metastasis. Although our knowledge is still incomplete, these studies are already uncovering important themes as to the physiological roles of Rho GTPase signaling in normal mammary gland development and function. Essential contributions of Rho proteins to breast cancer initiation, tumor progression, and metastatic dissemination have also been identified.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26677753      PMCID: PMC4771699          DOI: 10.1210/me.2015-1294

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  113 in total

1.  N-WASP-mediated invadopodium formation is involved in intravasation and lung metastasis of mammary tumors.

Authors:  Bojana Gligorijevic; Jeffrey Wyckoff; Hideki Yamaguchi; Yarong Wang; Evanthia T Roussos; John Condeelis
Journal:  J Cell Sci       Date:  2012-02-01       Impact factor: 5.285

2.  The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells.

Authors:  Steve Goodison; Jing Yuan; Derek Sloan; Ryung Kim; Cheng Li; Nicholas C Popescu; Virginia Urquidi
Journal:  Cancer Res       Date:  2005-07-15       Impact factor: 12.701

3.  IQGAP1 stimulates proliferation and enhances tumorigenesis of human breast epithelial cells.

Authors:  Lorraine Jadeski; Jennifer M Mataraza; Ha-Won Jeong; Zhigang Li; David B Sacks
Journal:  J Biol Chem       Date:  2007-11-02       Impact factor: 5.157

4.  RhoC is dispensable for embryogenesis and tumor initiation but essential for metastasis.

Authors:  Anne Hakem; Otto Sanchez-Sweatman; Annick You-Ten; Gordon Duncan; Andrew Wakeham; Rama Khokha; Tak W Mak
Journal:  Genes Dev       Date:  2005-08-17       Impact factor: 11.361

5.  Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone.

Authors:  Sijin Liu; Robert H Goldstein; Ellen M Scepansky; Michael Rosenblatt
Journal:  Cancer Res       Date:  2009-11-03       Impact factor: 12.701

6.  p190-B, a new member of the Rho GAP family, and Rho are induced to cluster after integrin cross-linking.

Authors:  P D Burbelo; S Miyamoto; A Utani; S Brill; K M Yamada; A Hall; Y Yamada
Journal:  J Biol Chem       Date:  1995-12-29       Impact factor: 5.157

7.  p190-B RhoGAP regulates mammary ductal morphogenesis.

Authors:  Geetika Chakravarty; Darryl Hadsell; William Buitrago; Jeffrey Settleman; Jeffrey M Rosen
Journal:  Mol Endocrinol       Date:  2003-03-13

8.  PAK signaling in cancer.

Authors:  Diana Zi Ye; Jeffrey Field
Journal:  Cell Logist       Date:  2012-04-01

9.  Overexpressed hPTTG1 promotes breast cancer cell invasion and metastasis by regulating GEF-H1/RhoA signalling.

Authors:  Y C Liao; J W Ruan; I Lua; M H Li; W L Chen; J R Y Wang; R H Kao; J H Chen
Journal:  Oncogene       Date:  2011-10-17       Impact factor: 9.867

Review 10.  Key stages in mammary gland development: the cues that regulate ductal branching morphogenesis.

Authors:  Mark D Sternlicht
Journal:  Breast Cancer Res       Date:  2005-12-05       Impact factor: 6.466

View more
  7 in total

Review 1.  Gap Junctions and Wnt Signaling in the Mammary Gland: a Cross-Talk?

Authors:  Sabreen F Fostok; Mirvat El-Sibai; Marwan El-Sabban; Rabih S Talhouk
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-09-07       Impact factor: 2.673

2.  The R-Enantiomer of Ketorolac Delays Mammary Tumor Development in Mouse Mammary Tumor Virus-Polyoma Middle T Antigen (MMTV-PyMT) Mice.

Authors:  Amanda S Peretti; Dayna Dominguez; Martha M Grimes; Helen J Hathaway; Eric R Prossnitz; Melanie R Rivera; Angela Wandinger-Ness; Donna F Kusewitt; Laurie G Hudson
Journal:  Am J Pathol       Date:  2017-11-21       Impact factor: 4.307

3.  Nucleoporin-93 reveals a common feature of aggressive breast cancers: robust nucleocytoplasmic transport of transcription factors.

Authors:  Nishanth Belugali Nataraj; Ashish Noronha; Joo Sang Lee; Soma Ghosh; Harsha Raj Mohan Raju; Arunachalam Sekar; Binyamin Zuckerman; Moshit Lindzen; Emilio Tarcitano; Swati Srivastava; Michael Selitrennik; Ido Livneh; Diana Drago-Garcia; Oscar Rueda; Carlos Caldas; Sima Lev; Tamar Geiger; Aaron Ciechanover; Igor Ulitsky; Rony Seger; Eytan Ruppin; Yosef Yarden
Journal:  Cell Rep       Date:  2022-02-22       Impact factor: 9.423

Review 4.  Influence of Fibroblasts on Mammary Gland Development, Breast Cancer Microenvironment Remodeling, and Cancer Cell Dissemination.

Authors:  Angelica Avagliano; Giuseppe Fiume; Maria Rosaria Ruocco; Nunzia Martucci; Eleonora Vecchio; Luigi Insabato; Daniela Russo; Antonello Accurso; Stefania Masone; Stefania Montagnani; Alessandro Arcucci
Journal:  Cancers (Basel)       Date:  2020-06-26       Impact factor: 6.639

5.  Connexin 43 Loss Triggers Cell Cycle Entry and Invasion in Non-Neoplastic Breast Epithelium: A Role for Noncanonical Wnt Signaling.

Authors:  Sabreen Fostok; Mirvat El-Sibai; Dana Bazzoun; Sophie Lelièvre; Rabih Talhouk
Journal:  Cancers (Basel)       Date:  2019-03-08       Impact factor: 6.639

6.  Integrin-Rac signalling for mammary epithelial stem cell self-renewal.

Authors:  Safiah Olabi; Ahmet Ucar; Keith Brennan; Charles H Streuli
Journal:  Breast Cancer Res       Date:  2018-10-22       Impact factor: 6.466

Review 7.  Rho GTPases: Big Players in Breast Cancer Initiation, Metastasis and Therapeutic Responses.

Authors:  Brock Humphries; Zhishan Wang; Chengfeng Yang
Journal:  Cells       Date:  2020-09-25       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.